Hot topics in MS research
Seeing what’s unseen in MS
Join Dr Jiwon Oh, Dr Enrique Alvarez and Dr Gregory Wu, as they explore hot topics in the field of multiple sclerosis (MS) research.
- Remind yourself of the key cellular players in MS
- Familiarise yourself with novel tools to measure neuro-axonal damage in MS
- Discover how new therapies could help overcome unmet needs in MS treatment
This content is from the EMD Serono-sponsored symposium ‘Seeing what’s unseen in MS’, presented at the American Academy of Neurology conference 2022 - created with expert faculty. EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany. Video content current as of April 2022. (c) 2022 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved.
Meet the experts
The spectrum of MS
Immunology of MS
sNfL and MS
BTK inhibitors modes of action
BTK inhibitors in clinical trials
In this session, symposium chair, Dr Jiwon Oh, is joined by fellow MS experts Dr Enrique Alvarez and Dr Gregory Wu to discuss some of the most exciting new developments in their field. This includes information on our evolving understanding of the role of the innate immune system in MS, as well as the potential use of new MS biomarkers, such as serum neurofilament light chain, and the importance of identifying novel therapeutic targets for this disease.
of interest
are looking at
saved
next event
Developed by EPG Health for Medthority. This meeting content has been developed in collaboration with Merck KGaA, Darmstadt, Germany and expert faculty. EPG Health received funding from Merck KGaA, Darmstadt, Germany.
These meetings are initiated, funded, and organised by Merck KGaA, Darmstadt, Germany.
EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada.
US-NONNI-01172. Date of preparation: July 2022.